Massachusetts Financial Services CO United Therapeutics Corp Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$205.19 - $232.99 $38,986 - $44,268	-190 Reduced 2.3%	8,066 $1.78 Million
Q1 2023 May 10, 2023	SELL	$212.99 - $276.17 $1.33 Million - $1.72 Million	-6,232 Reduced 43.01%	8,256 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $63,226 - $86,092	307 Added 2.16%	14,488 $4.03 Million
Q3 2022 Nov 09, 2022	SELL	$203.3 - $244.17 $395,011 - $474,422	-1,943 Reduced 12.05%	14,181 $2.97 Million
Q2 2022 Aug 09, 2022	BUY	$174.81 - $241.14 $55,239 - $76,200	316 Added 2.0%	16,124 $3.8 Million
Q1 2022 May 11, 2022	BUY	$166.16 - $213.96 $36,389 - $46,857	219 Added 1.4%	15,808 $2.84 Million
Q4 2021 Feb 10, 2022	SELL	$184.32 - $216.08 $1.09 Million - $1.27 Million	-5,888 Reduced 27.42%	15,589 $3.37 Million
Q3 2021 Nov 10, 2021	SELL	$179.86 - $214.88 $80,937 - $96,696	-450 Reduced 2.05%	21,477 $3.96 Million
Q2 2021 Aug 13, 2021	SELL	$170.47 - $211.93 $1.65 Million - $2.05 Million	-9,688 Reduced 30.64%	21,927 $3.93 Million
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $2.43 Million - $2.76 Million	-15,799 Reduced 33.32%	31,615 $5.29 Million
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $111,140 - $165,602	-1,091 Reduced 2.25%	47,414 $7.2 Million
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $1.09 Million - $1.32 Million	10,898 Added 28.98%	48,505 $4.9 Million
Q2 2020 Aug 11, 2020	BUY	$92.74 - $125.82 $679,784 - $922,260	7,330 Added 24.21%	37,607 $4.55 Million
Q1 2020 May 14, 2020	BUY	$79.39 - $115.35 $362,415 - $526,572	4,565 Added 17.75%	30,277 $2.87 Million
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $169,071 - $205,839	-2,159 Reduced 7.75%	25,712 $2.27 Million
Q3 2019 Nov 05, 2019	BUY	$74.85 - $85.99 $371,854 - $427,198	4,968 Added 21.69%	27,871 $2.22 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $276,021 - $438,419	3,629 Added 18.83%	22,903 $1.79 Million
Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $60,111 - $71,157	561 Added 3.0%	19,274 $2.26 Million
Q4 2018 Feb 08, 2019	BUY	$101.4 - $128.73 $134,253 - $170,438	1,324 Added 7.61%	18,713 $2.04 Million
Q3 2018 Oct 25, 2018	BUY	$113.81 - $129.46 $5,918 - $6,731	52 Added 0.3%	17,389 $2.22 Million
Q2 2018 Jul 30, 2018	SELL	$101.14 - $118.31 $89,711 - $104,940	-887 Reduced 4.87%	17,337 $1.96 Million
Q1 2018 May 04, 2018	BUY	$107.21 - $151.94 $1.05 Million - $1.49 Million	9,801 Added 116.36%	18,224 $2.05 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $192,218 - $245,224	1,621 Added 23.83%	8,423 $1.25 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $779,509 - $930,581	6,802	6,802 $797,000

Others Institutions Holding UTHR

# of Institutions

676

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.06 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$832 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account